Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | RYTM | NVCR | ||
| Company | Moonlake Immunotherapeutics | Rhythm Pharmaceuticals Inc | Novocure Ltd Ord Sh | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 52.35 | 56.27 | 30.49 | ||
| High | 53.51 | 56.31 | 30.59 | ||
| Low | 51.95 | 55.34 | 29.81 | ||
| Last | 52.72 | 55.58 | 30.42 | ||
| Change | +0.58 | -0.46 | -0.07 | ||
| % Change | +1.11% | -0.82% | -0.23% | ||
| Volume | 62,902 | 85,109 | 134,097 | ||
| 20-Day Average Volume | 175,732 | 555,372 | 1,904,179 | ||
| Previous Close | 52.14 | 56.04 | 30.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 53.25 | 57.82 | 28.61 | ||
| 20-Day Raw Stochastic | 33.79% | 21.44% | 77.98% | ||
| 20-Day Relative Strength | 51.89% | 47.73% | 63.80% | ||
| Weighted Alpha | -2.59 | +7.34 | +75.24 | ||
| Today's Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.99% since 12/17/24 | -2.21% since 12/17/24 | -5.09% since 12/17/24 | ||
| Low | 50.21 on 12/20/24 | 53.39 on 12/18/24 | 29.79 on 12/19/24 | ||
| High | 56.87 on 12/18/24 | 58.16 on 12/20/24 | 34.13 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -2.56% since 11/22/24 | -7.33% since 11/22/24 | +71.80% since 11/22/24 | ||
| Low | 50.21 on 12/20/24 | 53.39 on 12/18/24 | 17.46 on 11/26/24 | ||
| High | 58.26 on 12/17/24 | 63.44 on 11/27/24 | 34.13 on 12/18/24 | ||
| 3-Month | |||||
| %Chg | -2.45% since 09/24/24 | +8.40% since 09/24/24 | +85.39% since 09/24/24 | ||
| Low | 45.24 on 10/31/24 | 46.80 on 10/10/24 | 14.17 on 10/08/24 | ||
| High | 58.26 on 12/17/24 | 68.58 on 11/11/24 | 34.13 on 12/18/24 | ||
| 6-Month | |||||
| %Chg | +36.73% since 06/24/24 | +30.60% since 06/24/24 | +62.71% since 06/24/24 | ||
| Low | 38.65 on 06/26/24 | 39.46 on 06/28/24 | 14.17 on 10/08/24 | ||
| High | 58.26 on 12/17/24 | 68.58 on 11/11/24 | 34.13 on 12/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,332,006 | 3,444,050 | 3,299,048 | ||
| Shares Outstanding, K | 63,905 | 61,457 | 108,201 | ||
| Annual Sales | 0 | 77,430,000 | 509,340,000 | ||
| Annual Net Income | -36,010,000 | -184,680,000 | -207,040,000 | ||
| Last Quarter Sales | 0 | 33,250,000 | 155,100,000 | ||
| Last Quarter Net Income | -35,390,000 | -43,640,000 | -30,570,000 | ||
| 60-Month Beta | 1.31 | 2.14 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 11/07/24 | -0.73 on 11/05/24 | -0.28 on 10/30/24 | ||
| Latest Earnings Date | 11/12/24 | 11/05/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||